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Mechanisms underlying virulence properties of Campylobacter jejuni have historically been difficult to
identify. In this issue of Cell Host & Microbe, Hofreuter et al. (2008) show that C. jejuni’s ability to metabolize
glutamine, glutathione, and asparagine affects its ability to colonize specific host tissues. These findings
reflect the emerging theme of bacterial physiology directly impacting pathogenesis.Campylobacter jejuni is the leading cause
of bacterial-induced acute gastroenteritis
in the developed world, yet the precise
mechanisms by which it causes disease
remain unclear (Young et al., 2007).
Although it causes severe human disease,
C. jejuni harmlessly colonizes many ani-
mal species (i.e., birds and cows) and is
typically acquired through ingestion of
contaminated poultry, milk, or water.
Symptoms of campylobacteriosis range
from mild, watery diarrhea to severe
bloody diarrhea resembling dysentery.
C. jejuni can also invade and transcytose
host cells, and strains that are highly inva-
sive also tend to cause more severe
disease. In rare instances, infection with
C. jejuni can lead to more serious medical
sequelae, including the ascending bilat-
eral paralysis Guillain-Barre´ Syndrome.
In contrast to other, better-understood
enteric pathogens such as Salmonella,
Shigella, and E. coli spp., C. jejuni is quite
fastidious, with a complex metabolism
requiring microaerophilic and capnophilic
growth conditions. Furthermore, C. jejuni
is asaccharolytic, lacking the capacity
both to transport and catabolize most car-
bohydrates, and instead relies on amino
acids such as serine, glutamate, and
aspartate as primary carbon and energy
sources (Kelly, 2008).
Also in perplexing contrast to other
enteric pathogens, C. jejuni lacks many
‘‘classic’’ virulence factors, such as exo-
toxins and type III secretion systems for
injecting effector proteins into host cells.
Even the eagerly anticipated release of
the first sequenced C. jejuni genome
(strain 11168) in 2000 failed to identify
any obvious means by which the organ-
ism causes disease (Parkhill et al., 2000).However, the sequence did provide
significant insight into C. jejuni biology,
including the identification of several met-
abolic pathways, protein glycosylation
systems and a polysaccharide capsule,
and mechanisms underlying its high rate
of phase variation. The more recent
sequencing of additional strains, includ-
ing one known to be highly virulent and
invasive (strain 81-176), likewise did not
uncover new virulence factors (Fouts
et al., 2005; Hofreuter et al., 2006; Pear-
son et al., 2007). While this was surpris-
ing and initially somewhat disappointing,
these comparative genomics efforts did
show that the majority of strain-specific
differences occurred in metabolic genes,
suggesting their potential importance in
C. jejuni pathogenesis.
In this issue, Hofreuter et al. demon-
strate that two such variant genes, both
of which encode enzymes involved in
amino acid metabolism, play key roles in
tissue tropism of the virulent and invasive
C. jejuni strain 81-176 during host infec-
tion (Hofreuter et al., 2008).
The first enzyme, g-glutamyltranspepti-
dase (GGT), was identified as present in
the genome of strain 81-176 but not strain
11168 (Hofreuter et al., 2006). In that
study, an 81-176 strain deleted for GGT
was used to demonstrate that GGT is
required for mouse intestinal colonization
following oral infection. Similar findings
using a chick infection model and a differ-
ent GGT-harboring C. jejuni strain have
also been reported (Barnes et al., 2007).
GGT catalyzes the conversion of gluta-
thione and glutamine to glutamate. Ho-
freuter et al. now clearly demonstrate
that the ability of multiple C. jejuni strains
and clinical isolates to utilize glutamineCell Host & Microbe 4, Nor glutathione as a sole carbon source
absolutely depends on the presence of
GGT (Hofreuter et al., 2008). They further
demonstrate that this occurs via periplas-
mic conversion of glutamine or glutathi-
one to glutamate, which is subsequently
transported into the cytoplasm via the
Peb1A glutamate/aspartate binding pro-
tein. Interestingly, GGT was dispensable
for mouse liver colonization of strain
81-176 following intraperitoneal infection,
suggesting that the ability of C. jejuni to
disseminate systemically does not require
glutamine or glutathione utilization.
Conversely, this study also demon-
strates that a periplasmic isoform of
asparaginase (AnsB) is dispensable for
intestinal colonization but is important
for optimal liver colonization of strain
81-176. The authors elegantly show that
this is due not only to the presence of
ansB, but specifically to the presence of
an alternative ansB start codon and
downstream secretion signal sequence
(SS) found in strain 81-176 but not strain
11168. The SS confers periplasmic local-
ization to AnsB; using a series of strains
containing ansB isoforms harboring or
missing the SS, 81-176, and 11168 strains
complemented with each other’s ansB
genes, and a survey of numerous clinical
isolates, Hofreuter et al. also clearly
show that periplasmic AnsB is required
for C. jejuni to utilize asparagine as a
sole carbon source. As above, this occurs
via deamination of asparagine to aspar-
tate, followed by Peb1A-dependent as-
partate transport to the cytoplasm.
This work collectively suggests that
C. jejuni utilizes glutamine and/or glutathi-
one for intestinal but not liver coloniza-
tion, and asparagine for liver but notovember 13, 2008 ª2008 Elsevier Inc. 409
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specific tissue tropism for specific
nutrient utilization genes. These findings
are particularly relevant for a pathogen
such as C. jejuni given its lack of hallmark
virulence factors and reliance on amino
acids as carbon sources. The thorough
molecular genetic analyses undertaken
to demonstrate these points, especially
the AnsB SS requirement, are commend-
able, especially in an organism that is still
much more difficult to manipulate geneti-
cally than most other enteric pathogens.
The periplasmic AnsB and GGT obser-
vations presented in this study may also
have direct implications for other Gram-
negative pathogens, including 3-proteo-
bacterial species closely related to
C. jejuni. SignalP analyses indicate that
periplasmic AnsB asparaginases occur
in other bacteria that can localize to the
liver. One of these organisms is the hepa-
totropic 3-proteobacterium Helicobacter
hepaticus. In contrast, all sequenced
genomes of the stomach-restricted path-
ogen Helicobacter pylori encode only
a predicted cytoplasmic asparaginase.
Periplasmic AnsB proteins are likewise
predicted in the genomes of E. coli,
Salmonella, Shigella, Yersinia, Francisella,
and Klebsiella spp., each of which can
disseminate to the liver, but not in bacteria
such as Vibrio cholerae or Neisseria gon-
orrhoeae, which are primarily restricted
to other body compartments.
In contrast, GGT may be more important
for pathogens that colonize mucosal tis-
sues. BLAST analyses indicate that GGT
is not found in H. hepaticus but is present
in all sequenced H. pylori strains; indeed,
H. pylori GGT activity has been shown to
be important for gastric colonization as
well as for uptake of glutathione and gluta-
mine from the extracellular environment
(McGovern et al., 2001; Shibayama et al.,
2007). GGT is also found in most strains
of nearly all of the other abovementioned
Gram-negative pathogens.
The above In silico analyses together
with the data presented in Hofreuter et al.,
lend themselves to several intriguing in-
terpretations. For instance, while tissue
tropism is clearly multifactorial, the poten-
tial role of periplasmic AnsB and aspara-
gine metabolism in pathogen persistence
in the liver and possibly dissemination to
other organs is an exciting notion to con-
sider. The presence of GGT in numerous410 Cell Host & Microbe 4, November 13, 200mucosal pathogens may also be consis-
tent with defined roles for mammalian
GGT, glutamine, and glutathione in main-
taining mucosal tissue health. Glutamine
and glutathione in particular are known
to exert protective effects involving both
the innate and adaptive immune systems.
Both H. pylori and C. jejuni GGT have
been implicated as inducing host cell ap-
optosis (Barnes et al., 2007; Shibayama
et al., 2007); one ensuing hypothesis is
that this may in part be due to glutamine
or glutathione ‘‘theft’’ from the gastric
and intestinal mucosa. Future work ex-
ploring potential roles in other pathogens
for asparagine utilization in liver dissemi-
nation and glutamine and/or glutathione
utilization in mucosal damage may shed
light on these hypotheses.
This study also raises several intriguing
questions specific to C. jejuni pathogene-
sis. First, the paradox of C. jejuni’s preva-
lence in the environment given its fastidious
nature is a key question in C. jejuni re-
search, and it will be interesting toestablish
if GGT and/or periplasmic AnsB participate
in growth or survival during lower-nutrient
conditions as encountered in water, milk,
and other non-in vivo environments. Sec-
ond, although a potential role for GGT in
host cell invasion and intracellular survival
has been described (Barnes et al., 2007),
this has not been explored for periplasmic
AnsB. Invasion and intracellular survival
are typically associated with virulence,
and a correlation between them, AnsB,
and liver dissemination would provide ad-
ditional mechanistic insight into C. jejuni
virulenceproperties.Finally, isthereadirect
correlation between GGT and periplasmic
AnsB with C. jejuni disease? All of the clin-
ical strains surveyed in this study for pres-
ence or absence of GGT and the AnsB
SS, including 11168, were originally human
isolates and thus presumably capable of
causing diarrhea. Although this information
isnot currently available (J. Galan, personal
communication), it would be very interest-
ing to know if these strains are also asso-
ciated with watery versus bloody diarrhea
or other clinical differences. Along similar
lines, it will be important to establish intes-
tinal and liver colonization properties of
clinical strains not harboring GGT or the
AnsB SS. This will allow better insight into
whether the observations described repre-
sent a general trend or are specific to the
strain investigated; if the latter, it will also8 ª2008 Elsevier Inc.be interesting to explore other means by
which strains that cannot utilize glutamine,
glutathione, and/or asparagine have
evolved to establish tissue tropism.
In summary, this work both provides
key new insight into C. jejuni pathogene-
sis and highlights the underappreciated
but emerging theme of the importance of
physiology and basic metabolic pro-
cesses in both pathogen tropism and
pathogenesis in general. Examples of
this connection have been published for
other pathogens, but as with C. jejuni, his-
torically have not been as well acknowl-
edged in terms of understanding virulence
as have studies of more traditional viru-
lence factors. The direct connection be-
tween tissue tropism and specific nutrient
utilization demonstrated here provides
clear proof that metabolism and patho-
genesis are intimately interconnected;
further research into these areas should
yield additional new angles linking these
aspects of pathogen biology.REFERENCES
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